HEADER HYDROLASE 18-FEB-98 1A5W TITLE ASV INTEGRASE CORE DOMAIN WITH HIV-1 INTEGRASE INHIBITOR Y3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC CORE DOMAIN; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: P03354 FRAGMENT OF POLYPROTEIN POL-RSVP SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ROUS SARCOMA VIRUS (STRAIN SCHMIDT-RUPPIN); SOURCE 3 ORGANISM_TAXID: 11889; SOURCE 4 STRAIN: SCHMIDT-RUPPIN; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PRC23IN(52-207); SOURCE 8 OTHER_DETAILS: SEE JRNL REFERENCE KEYWDS HYDROLASE, ENDONUCLEASE, HIV-1 INTEGRASE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR J.LUBKOWSKI,F.YANG,J.ALEXANDRATOS,A.WLODAWER REVDAT 5 22-MAY-24 1A5W 1 REMARK REVDAT 4 02-AUG-23 1A5W 1 REMARK SEQADV REVDAT 3 24-FEB-09 1A5W 1 VERSN REVDAT 2 01-APR-03 1A5W 1 JRNL REVDAT 1 27-MAY-98 1A5W 0 JRNL AUTH J.LUBKOWSKI,F.YANG,J.ALEXANDRATOS,A.WLODAWER,H.ZHAO, JRNL AUTH 2 T.R.BURKE JR.,N.NEAMATI,Y.POMMIER,G.MERKEL,A.M.SKALKA JRNL TITL STRUCTURE OF THE CATALYTIC DOMAIN OF AVIAN SARCOMA VIRUS JRNL TITL 2 INTEGRASE WITH A BOUND HIV-1 INTEGRASE-TARGETED INHIBITOR. JRNL REF PROC.NATL.ACAD.SCI.USA V. 95 4831 1998 JRNL REFN ISSN 0027-8424 JRNL PMID 9560188 JRNL DOI 10.1073/PNAS.95.9.4831 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.0 REMARK 3 NUMBER OF REFLECTIONS : 11261 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1126 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 62.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 875 REMARK 3 BIN R VALUE (WORKING SET) : 0.2099 REMARK 3 BIN FREE R VALUE : 0.2180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 92 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1124 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 126 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.420 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.31 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.980 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX_FY.PRO REMARK 3 PARAMETER FILE 2 : PARAM_SIMPLE.INHIBITOR REMARK 3 PARAMETER FILE 3 : PARAM19.SOLV REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX_FY.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH_SIMPLE.INHIBITOR REMARK 3 TOPOLOGY FILE 3 : TOPH19.SOLV REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 ATOMIC OCCUPANCIES OF DISORDERED ATOMS ARE SET TO 0.00 IN REMARK 3 THE COORDINATES. REMARK 4 REMARK 4 1A5W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170431. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-JUN-97 REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12682 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 7.260 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07200 REMARK 200 FOR THE DATA SET : 10.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.37900 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PDB ENTRY 1ASV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 4000, 10% ISOPROPANOL, 0.1M NA REMARK 280 CITRATE PH 5.6 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.50950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 33.35350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 33.35350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 60.76425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 33.35350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 33.35350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 20.25475 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 33.35350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 33.35350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 60.76425 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 33.35350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 33.35350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 20.25475 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 40.50950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE AUTHOR MAINTAINS THAT THE BIOLOGICAL UNIT IS NOT YET REMARK 300 KNOWN. THE MINIMUM MULTIMER IS BELIEVED TO CONTAIN AT LEAST THE REMARK 300 DIMER GENERATED BT THE TRANSFORMATION IN REMARK 350, SHOWN IN BOTH REMARK 300 HIV-1 AND ASV INTEGRASE CORE DOMAIN STRUCTURES. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 66.70700 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 66.70700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 121.52850 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 52 REMARK 465 ARG A 53 REMARK 465 GLU A 200 REMARK 465 ARG A 201 REMARK 465 GLY A 202 REMARK 465 GLU A 203 REMARK 465 ASN A 204 REMARK 465 THR A 205 REMARK 465 LYS A 206 REMARK 465 THR A 207 REMARK 465 ASN A 208 REMARK 465 LEU A 209 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLY A 54 REMARK 475 PRO A 147 REMARK 475 GLY A 148 REMARK 475 ASN A 149 REMARK 475 SER A 150 REMARK 475 GLN A 151 REMARK 475 GLY A 152 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 95 CG CD NE CZ NH1 NH2 REMARK 480 ASN A 122 CG OD1 ND2 REMARK 480 LYS A 129 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 55 -14.96 -44.68 REMARK 500 ASN A 149 17.62 55.98 REMARK 500 GLN A 153 98.76 -169.56 REMARK 500 LYS A 178 -128.91 -120.71 REMARK 500 HIS A 198 -32.30 65.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ACTIVE SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Y3 A 1 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE APPARENT DISCREPANCY BETWEEN THE SEQUENCE PRESENTED REMARK 999 HERE AND THE "POL_RSVP" SEQUENCE IS A RESULT OF VIRAL REMARK 999 STRAIN VARIATION. THE STRAIN USED FOR THIS WORK, REMARK 999 "ROUS SARCOMA VIRUS SCHMIDT-RUPPIN B", COMPARED TO REMARK 999 "POL-RSVP" SEQUENCE DIFFERS AT TWO POSITIONS WITH THE REMARK 999 CONSERVATIVE AMINO ACID RESIDUE DIFFERENCES NOTED REMARK 999 (VAL -> ALA 101 AND ARG -> LYS 166). DBREF 1A5W A 52 207 UNP P03354 POL_RSVP 624 779 SEQADV 1A5W ALA A 101 UNP P03354 VAL 673 VARIANT SEQADV 1A5W LYS A 166 UNP P03354 ARG 738 VARIANT SEQRES 1 A 158 PRO ARG GLY LEU GLY PRO LEU GLN ILE TRP GLN THR ASP SEQRES 2 A 158 PHE THR LEU GLU PRO ARG MET ALA PRO ARG SER TRP LEU SEQRES 3 A 158 ALA VAL THR VAL ASP THR ALA SER SER ALA ILE VAL VAL SEQRES 4 A 158 THR GLN HIS GLY ARG VAL THR SER VAL ALA ALA GLN HIS SEQRES 5 A 158 HIS TRP ALA THR ALA ILE ALA VAL LEU GLY ARG PRO LYS SEQRES 6 A 158 ALA ILE LYS THR ASP ASN GLY SER CYS PHE THR SER LYS SEQRES 7 A 158 SER THR ARG GLU TRP LEU ALA ARG TRP GLY ILE ALA HIS SEQRES 8 A 158 THR THR GLY ILE PRO GLY ASN SER GLN GLY GLN ALA MET SEQRES 9 A 158 VAL GLU ARG ALA ASN ARG LEU LEU LYS ASP LYS ILE ARG SEQRES 10 A 158 VAL LEU ALA GLU GLY ASP GLY PHE MET LYS ARG ILE PRO SEQRES 11 A 158 THR SER LYS GLN GLY GLU LEU LEU ALA LYS ALA MET TYR SEQRES 12 A 158 ALA LEU ASN HIS PHE GLU ARG GLY GLU ASN THR LYS THR SEQRES 13 A 158 ASN LEU HET Y3 A 1 23 HETNAM Y3 4-ACETYLAMINO-5-HYDROXYNAPHTHALENE-2,7-DISULFONIC ACID FORMUL 2 Y3 C12 H11 N O8 S2 FORMUL 3 HOH *126(H2 O) HELIX 1 1 PRO A 69 MET A 71 5 3 HELIX 2 2 SER A 98 LEU A 112 1 15 HELIX 3 3 SER A 124 THR A 127 1 4 HELIX 4 4 LYS A 129 TRP A 138 1 10 HELIX 5 5 ALA A 154 GLY A 173 1 20 HELIX 6 6 THR A 182 LEU A 196 1 15 SHEET 1 A 5 ILE A 88 HIS A 93 0 SHEET 2 A 5 TRP A 76 ASP A 82 -1 N THR A 80 O VAL A 89 SHEET 3 A 5 ILE A 60 LEU A 67 -1 N THR A 66 O LEU A 77 SHEET 4 A 5 ALA A 117 LYS A 119 1 N ALA A 117 O TRP A 61 SHEET 5 A 5 ALA A 141 THR A 143 1 N ALA A 141 O ILE A 118 CISPEP 1 ALA A 72 PRO A 73 0 8.28 SITE 1 ACT 3 ASP A 64 ASP A 121 GLU A 157 SITE 1 AC1 10 GLN A 62 LYS A 119 GLY A 145 ILE A 146 SITE 2 AC1 10 GLN A 153 ALA A 154 MET A 155 ARG A 158 SITE 3 AC1 10 HOH A 274 HOH A 287 CRYST1 66.707 66.707 81.019 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014991 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014991 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012343 0.00000